# Prothena (PRTA) — News

PRTA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/prta/news

## Recent headlines

- [Alzheimer stocks rose in regular trading, with Eli Lilly up 3.4%, Biogen gaining 1.6% and Prothena rising 1.2%.](https://www.ainvest.com/news/alzheimer-stocks-rose-regular-trading-eli-lilly-3-4-biogen-gaining-1-6-prothena-rising-1-2-2610) — AInvest Wire, Oct 14, 2026
  Alzheimer's-related stocks experienced gains in regular trading on October 14, 2026, reflecting ongoing investor interest in the sector. Eli Lilly shares rose 3.4%, Biogen increased by 1.6%, and Prothena Corporation (PRTA) added 1.2% to its value. These movements occurred amid continued research…
- [Alzheimer stocks rose in regular trading, with Eli Lilly gaining 2.37%, Biogen up 2.12% and Prothena rising 1.18%.](https://www.ainvest.com/news/alzheimer-stocks-rose-regular-trading-eli-lilly-gaining-2-37-biogen-2-12-prothena-rising-1-18-2610-9) — AInvest Wire, Oct 7, 2026
  Alzheimer's-related stocks saw gains in regular trading on October 7, 2026, as investor sentiment remained positive amid ongoing developments in the sector. Eli Lilly (NYSE: LLY) rose 2.37%, Biogen (NASDAQ: BIIB) increased by 2.12%, and Prothena Corporation plc (NASDAQ: PRTA) added 1.18% to its…
- [Prothena: May earn $55 mln clinical milestone payment if Bristol Myers Squibb decides to advance PRX019; BMS decision expected year end 2026](https://www.ainvest.com/news/prothena-earn-55-mln-clinical-milestone-payment-bristol-myers-squibb-decides-advance-prx019-bms-decision-expected-year-2026-2608) — AInvest Wire, Aug 6, 2026
  Prothena Corporation plc (NASDAQ: PRTA) has completed the Phase 1 study for PRX019, a potential treatment for neurodegenerative diseases being developed in collaboration with Bristol Myers Squibb (BMS). The company could potentially earn a $55 million clinical milestone payment if BMS decides to…
- **Important** — [Prothena earned $50 million milestone payment from Novo Nordisk](https://www.ainvest.com/news/prothena-earned-50-million-milestone-payment-novo-nordisk-2603) — AInvest Wire, Mar 9, 2026
- **Important** — Prothena preparing for a potential sale - Bloomberg — AInvest Wire, Oct 16, 2023

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).